Top Generics Based on Retail Dollar Sales
2006
RANK DRUG DOLLAR SALES
1 Hydrocodone/APAP $1,622,889,152
2 Simvastatin 1,390,478,902
3 Azithromycin 1,216,98…
MENLO PARK, Calif. — Depomed, Inc. (NASDAQ:DEPO) today announced that it has completed enrollment in a Phase II clinical trial to evaluate its Gabapentin GR compound for the treatment of patients with painful diabetic peripheral neuropathy (DPN). The company expects data from the approximately 150-…
MENLO PARK, Calif. — Depomed, Inc. (Nasdaq:DEPO) today announced that it has completed enrollment for the Phase II clinical trial evaluating the safety and efficacy of its Gabapentin extended release tablets to treat patients with postherpetic neuralgia, a long-lasting pain condition associated with nerve damage from herpes zoster, or shingles, infection.
“This is …
Company to Seek Labeling for Gabapentin GR as a New, Non-Hormonal Hot Flash Therapy
MENLO PARK, Calif. — Depomed, Inc. (NASDAQ:DEPO) today announced that it has obtained an exclusive sublicense from PharmaNova, Inc. to a U.S. pate…
Pfizer Inc. has voluntarily recalled one lot of 100-mg capsules of Neurontin (gabapentin) because of a mechanical failure that resulted in some empty or partly filled capsules.
Most Popular
Productivity Benchmarks And the Process of Benchmarking
7 Career Myths That Could Stall A Career!
Public Speaking Fear To Public Speaking Excellence
Business Plan Sample
Conflict - An Essential Ingredient for Growth
…
WASHINGTON — Gabapentin brought greater relief of symptoms to patients with primary fibromyalgia than placebo in a randomized, double-blind trial, Dr. Lesley M. Arnold reported at the annual meeting of the American College of Rheumatology.
Gabapentin is known to be effective for neuropathic pain conditions, a…
* Clinical Question
Is high-dose gabapentin as effective as usual-dose estrogen for the treatment of postmenopausal hot flashes?
* Bottom Line
In this small study, high-dose gabapentin (Neurontin) was as effective as the usual dose of conjugated equine estrogens (Premarin) for the treatment of menopausal vasomotor symptoms. Larger studies are needed to confirm this result. (LOE=1b)
Study Design
Randomiz…
